Hugel, Inc.
A biopharmaceutical company developing and distributing medical aesthetic products.
145020 | KO
Overview
Corporate Details
- ISIN(s):
- KR7145020004
- LEI:
- Country:
- South Korea
- Address:
- 강원특별자치도 춘천시 동내면 거두단지1길 23 -, 춘천시
- Website:
- https://www.hugel-inc.com/
- Sector:
- Manufacturing
Description
Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-08-10 00:00 |
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.5 KB | ||
| 2022-08-10 00:00 |
기업설명회(IR)개최
|
Korean | 7.1 KB | ||
| 2022-08-03 00:00 |
결산실적공시예고
|
Korean | 4.0 KB | ||
| 2022-08-03 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2022-07-25 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 90.8 KB | ||
| 2022-07-13 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 5.3 KB | ||
| 2022-07-08 00:00 |
신탁계약에의한취득상황보고서
|
Korean | 24.4 KB | ||
| 2022-07-07 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 스페인 품목허가 획득)
|
Korean | 8.8 KB | ||
| 2022-06-29 00:00 |
임시주주총회결과
|
Korean | 8.0 KB | ||
| 2022-06-16 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛,100유닛의 캐나다 품목허가 획득)
|
Korean | 8.6 KB | ||
| 2022-06-14 00:00 |
주주총회소집공고
|
Korean | 121.8 KB | ||
| 2022-06-14 00:00 |
의결권대리행사권유참고서류
|
Korean | 36.9 KB | ||
| 2022-06-13 00:00 |
신탁계약해지결과보고서
|
Korean | 16.5 KB | ||
| 2022-06-13 00:00 |
기업설명회(IR)개최
|
Korean | 7.1 KB | ||
| 2022-06-03 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 폴란드 품목허가 획득)
|
Korean | 8.5 KB |
Automate Your Workflow. Get a real-time feed of all Hugel, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hugel, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hugel, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
